Ethic Inc’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Other funds holding PTGX
Ethic Inc's PTGX Position: Q3 2026 in Review
Ethic Inc opened a new position in Protagonist Therapeutics (PTGX) in Q3 2026: 3,441 shares worth $485K. The stake represents 0.01% of the portfolio and ranks #1019 among its holdings.
380 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.
- Ethic Inc held 3,441 shares of Protagonist Therapeutics worth $485K as of Q3 2026.
- Protagonist Therapeutics was a new Ethic Inc position in Q3 2026.
- Protagonist Therapeutics made up 0.01% of Ethic Inc's portfolio in Q3 2026, its #1019 holding.
- 380 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.
Based on Ethic Inc's 13F filing for Q3 2026, filed 3 Nov 2026.